A National Cancer Clinical Trials System for the 21st Century:

Reinvigorating the NCI Cooperative Group Program

Status: Available Now

Size: 316 pages, 6 x 9

Publication Year:2010

Print	List Price


PAPERBACK ISBN-10: 0-309-15186-4 ISBN-13: 978-0-309-15186-3	$64.25	Add to Cart

PDF			About PDF

Authors:
Sharyl J. Nass, Harold L. Moses, and John Mendelsohn, Editors; Committee on Cancer Clinical Trials and the NCI Cooperative Group Program; Institute of Medicine
Authoring Organizations

Description:

Paste into your Web page:

<!-- Start NAP Book Display -->
<object classid="clsid:d27cdb6e-ae6d-11cf-96b8-444553540000" codebase="http://download.macromedia.com/pub/shockwave/cabs/flash/swflash.cab#version=8,0,0,0" width="175" height="250" id="napbookwrapper" align="middle">
<param name="allowScriptAccess" value="always" />
<param name="movie" value="http://www.nap.edu/napbookwrapper.swf" />
<param name="quality" value="high" />
<param name="wmode" value="transparent" />
<param name="flashvars" value="wid=542265292013051975011&record_id=12879" />
<embed src="http://www.nap.edu/napbookwrapper.swf" quality="high" flashvars="wid=542265292013051975011&record_id=12879" wmode="transparent" bgcolor="#ffffff" width="175" height="250" name="napbookwrapper" align="middle" allowScriptAccess="always" allowFullScreen="false" type="application/x-shockwave-flash" pluginspage="http://www.macromedia.com/go/getflashplayer"></embed>
</object>

Preview

Free Resources

Full Text
Jump to this book's table of contents to begin reading online for free.

PDF Summary
Download the summary in PDF.

Reprint Permission
Request permission to license or reprint the book's content through Copyright Clearance Center's Rightslink.

Request Permission to Distribute a PDF

Request Translation Rights

Questions About Rights and Permissions?

Table of Contents
Select a link below to start reading online free!
Front Matter	i-xviii
Executive Summary	1-4	(skim)
Overview of Conclusions and Recommendations	5-40	(skim)
1 Introduction	41-76	(skim)
2 The Science of Developing Cancer Therapy	77-120	(skim)
3 Operations, Oversight, and Funding of Cancer Clinical Trials	121-190	(skim)
4 Physician and Patient Participation in Cancer Clinical Trials	191-234	(skim)
Appendix A: Previous and Ongoing Analyses Undertaken by NCI	235-258	(skim)
Appendix B: Committee Member and Staff Biographies	259-274	(skim)
Acronyms	275-278	(skim)
Glossary	279-298	(skim)

Description

The National Cancer Institute's (NCI) Clinical Trials Cooperative Group Program has played a key role in developing new and improved cancer therapies. However, the program is falling short of its potential, and the IOM recommends changes that aim to transform the Cooperative Group Program into a dynamic system that efficiently responds to emerging scientific knowledge; involves broad cooperation of stakeholders; and leverages evolving technologies to provide high-quality, practice-changing research.

A National Cancer Clinical Trials System for the 21st Century:

Reinvigorating the NCI Cooperative Group Program

Citation Manager

Description

Authoring Organizations

Search This Book

SIGN UP FOR...